Adverse Neuropsychiatric Events Associated with Varenicline: A Case Series
Varenicline is an orally administered α4β2 nicotinic acetylcholine (Ach) receptor, partial agonist. This drug has been known to be more effective in the treatment of nicotine withdrawal than bupropion and nicotine replacement therapies. Besides this effectiveness, it has some systemic and...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Psychopharmacology Association
2021-03-01
|
| Seri Bilgileri: | Psychiatry and Behavioral Sciences |
| Konular: | |
| Online Erişim: | http://www.ejmanager.com/fulltextpdf.php?mno=302645354 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|